What is the brand name for empagliflozin?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 26, 2026 • View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Brand Name for Empagliflozin

The brand name for empagliflozin is Jardiance®. 1

Medication Details

  • Empagliflozin is marketed under the trade name Jardiance® and is available in 10 mg and 25 mg tablet formulations for oral administration. 1

  • The medication was initially approved by the FDA in 2014 and is manufactured by Boehringer Ingelheim Pharmaceuticals, Inc. 1

  • Jardiance® is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus and to reduce the risk of cardiovascular death in adult patients with type 2 diabetes mellitus and established cardiovascular disease. 1

Clinical Context

  • Empagliflozin belongs to the sodium-glucose cotransporter-2 (SGLT2) inhibitor class, which works by reducing renal reabsorption of filtered glucose and increasing urinary glucose excretion. 2

  • The EMPA-REG OUTCOME trial demonstrated that empagliflozin (Jardiance®) reduced the composite outcome of myocardial infarction, stroke, and cardiovascular death by 14% and cardiovascular death by 38% in patients with type 2 diabetes and existing cardiovascular disease. 3

  • Beyond diabetes management, Jardiance® has been shown to provide benefits in heart failure and chronic kidney disease, with approval for use in patients with eGFR ≥20 mL/min/1.73 m² for renal and cardiovascular protection. 4

References

2
Guideline

Empagliflozin Clinical Applications and Efficacy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

3
Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

4
Guideline

Empagliflozine for Chronic Kidney Disease

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Related Questions

What is another name for Jardiance (empagliflozin)?
Is empagliflozin (Jardiance) appropriate for an adult with type 2 diabetes who needs additional glucose lowering beyond diet, exercise and metformin?
How does Jardiance (empagliflozin) work?
What is the indication for Jardiance (empagliflozin)?
Can Jardiance (empagliflozin) be used to treat patients with type 2 diabetes and premature ventricular contractions (PVCs)?
In an adult with moderate-to-severe chronic obstructive pulmonary disease (COPD) and frequent symptoms or ≥2 exacerbations in the past year, how does using Trelegy Ellipta (fluticasone furoate 100 µg + umeclidinium 62.5 µg + vilanterol 25 µg) compare to a regimen of tiotropium 2.5 µg (long‑acting muscarinic antagonist, LAMA) combined with Combivent (ipratropium 20 µg + albuterol 100 µg; short‑acting muscarinic antagonist, SAMA + short‑acting β2‑agonist, SABA)?
Should patients who have undergone an allogeneic hematopoietic stem‑cell transplant wear surgical masks (and have visitors wear masks) to prevent respiratory infections, and is routine masking also recommended for autologous transplant or other neutropenic patients?
How should I treat a spider bite and when is urgent medical care needed?
What is the appropriate clindamycin dosing (oral and intravenous) for an adult with treatment‑failure streptococcal pharyngitis who is taking verapamil and may be unable to tolerate oral medication?
Can ibuprofen (Motrin) be administered to a healthy 1‑year‑old child, and what is the appropriate weight‑based dosing?
Is it safe to prescribe cephalexin to an adult diabetic patient with no known β‑lactam allergy and normal renal function?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question